Indies Pharma Jamaica Limited announced earnings results for the third quarter ended July 31, 2021. For the third quarter, the company announced sales was JMD 207.635 million compared to JMD 164.874 million a year ago. Operating income was JMD 61.856 million compared to JMD 46.015 million a year ago. Net income was JMD 42.582 million compared to JMD 49.388 million a year ago. Basic earnings per share from continuing operations was JMD 0.01 compared to JMD 0.02 a year ago. For the nine months, sales was JMD 633.295 million compared to JMD 565.833 million a year ago. Operating income was JMD 152.661 million compared to JMD 152.853 million a year ago. Net income was JMD 103.583 million compared to JMD 158.782 million a year ago. Basic earnings per share from continuing operations was JMD 0.08 compared to JMD 0.12 a year ago.